<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>131(4)</volume><submitter>Angelidi AM</submitter><pubmed_abstract>Severe insulin resistance syndromes are a heterogeneous group of rare disorders characterized by profound insulin resistance, substantial metabolic abnormalities, and a variety of clinical manifestations and complications. The etiology of these syndromes may be hereditary or acquired, due to defects in insulin potency and action, cellular responsiveness to insulin, and/or aberrations in adipose tissue function or development. Over the past decades, advances in medical technology, particularly in genomic technologies and genetic analyses, have provided insights into the underlying pathophysiological pathways and facilitated the more precise identification of several of these conditions. However, the exact cellular and molecular mechanisms of insulin resistance have not yet been fully elucid</pubmed_abstract><journal>The Journal of clinical investigation</journal><pagination>142245</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7880309</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Severe insulin resistance syndromes.</pubmed_title><pmcid>PMC7880309</pmcid><pubmed_authors>Filippaios A</pubmed_authors><pubmed_authors>Angelidi AM</pubmed_authors><pubmed_authors>Mantzoros CS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Severe insulin resistance syndromes.</name><description>Severe insulin resistance syndromes are a heterogeneous group of rare disorders characterized by profound insulin resistance, substantial metabolic abnormalities, and a variety of clinical manifestations and complications. The etiology of these syndromes may be hereditary or acquired, due to defects in insulin potency and action, cellular responsiveness to insulin, and/or aberrations in adipose tissue function or development. Over the past decades, advances in medical technology, particularly in genomic technologies and genetic analyses, have provided insights into the underlying pathophysiological pathways and facilitated the more precise identification of several of these conditions. However, the exact cellular and molecular mechanisms of insulin resistance have not yet been fully elucid</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-04T19:53:48.892Z</modification><creation>2025-04-04T19:53:48.892Z</creation></dates><accession>S-EPMC7880309</accession><cross_references><pubmed>33586681</pubmed><doi>10.1172/jci142245</doi><doi>10.1172/JCI142245</doi></cross_references></HashMap>